Investment in R&D power the automated colony counter market

The global automated colony counter market was capitalized at almost USD 332.6 million in the year 2017 and it is likely to cross almost USD 450.3 million by 2024, growing at a CAGR of over 7.1 percent from 2017 to 2024, projects Zion Market Research. The major factor that will power the development of the market is the rising requirement for automation in different healthcare applications. Rising investments for R&D to improve the automation in clinical labs for more accurate and precise results will power the development of the automated colony counter market in the foreseeable period. There will be a rising demand for the market owing to its requirement for reduced time and cost and improved accuracy.

The automatic colony counter provides traceable and quick counting results. Clinical microbiology has relied on an extremely skilled and technical workforce to process, receive, and interpret outcome from a wide series of clinical specimens with restricted help from automation. Fewer available skilled workers and ever-rising specimen volumes have led labs to increasingly look for automated solutions for clinical and microbiology sectors, powering the automated colony counter market. Adoption of the automated equipment and rising clinical infrastructure in the medium and small medical labs are the major factors that are activating the development of the automated colony counter market.